Journal Reviews

Ophthalmologica journal cover image.

Post hoc analysis of the CANTREAT randomised trial

1 December 2023 | | Retina / Uvea / Vitreous | Age-related macular degeneration, Randomized clinical trial, Ranibizumab, Treat-and-extend

CANTREAT, a Canadian multicentre two-year randomised trial compares treat and extend treatment (T&E) relative to the monthly administration of Ranibizumab in nAMD. Two-hundred and eighty-five treatment-naïve patients with nAMD were randomised to receive either a once-monthly dosing or T&E regimen...